The Relationship Between Internal and External Dose: Some General Results Based on a Generic Compartmental Model.

(non)linear kinetics KMD inflection point internal-to-external-dose relationship kinetically-derived maximum dose saturation

Journal

Toxicological sciences : an official journal of the Society of Toxicology
ISSN: 1096-0929
Titre abrégé: Toxicol Sci
Pays: United States
ID NLM: 9805461

Informations de publication

Date de publication:
01 09 2020
Historique:
pubmed: 10 6 2020
medline: 22 7 2021
entrez: 10 6 2020
Statut: ppublish

Résumé

Statements on how the internal-to-external-dose (IED) relationship looks like are often based on qualitative toxicokinetic arguments. For example, the recently proposed kinetically derived maximum dose (KMD) states that the IED relationship must have an inflection point, due to saturation of underlying processes like metabolism or absorption. However, such statements lack a solid quantitative foundation. Therefore, we derived expressions for the IED relationship for a number of scenarios based on a generic compartmental model involving saturation. The scenarios included repeated or single dose, and saturable metabolism or saturable absorption. For some of these scenarios, an explicit expression for the IED relationship can be derived, for others only implicit expressions can be established, which need to be evaluated numerically. The results show that saturable processes will lead to an IED relationship that is nonlinear over the whole dose range, ie, it can be approximated by a linear relationship at the lower end, whereas the approximation will become gradually poorer with increasing doses. The finding that saturation does not lead to an inflection point in the IED relationship, as assumed in the KMD, implies that the KMD is not a valid approach for selecting the top dose in toxicological studies. An additional use of our results is that the derived explicit expressions of the IED relationship can be fitted to IED data, and, possibly, for extrapolation outside the observed dose range.

Identifiants

pubmed: 32514576
pii: 5854880
doi: 10.1093/toxsci/kfaa082
doi:

Substances chimiques

Drugs, Generic 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

60-70

Informations de copyright

© The Author(s) 2020. Published by Oxford University Press on behalf of the Society of Toxicology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Auteurs

Wout Slob (W)

National Institute for Public Health and the Environment (RIVM), VPZ, 3720 BA Bilthoven, The Netherlands.

Marco J Zeilmaker (MJ)

National Institute for Public Health and the Environment (RIVM), VPZ, 3720 BA Bilthoven, The Netherlands.

Rudolf T Hoogenveen (RT)

National Institute for Public Health and the Environment (RIVM), VPZ, 3720 BA Bilthoven, The Netherlands.

Articles similaires

Using Bayh-Dole Act March-In Rights to Lower US Drug Prices.

Lisa Larrimore Ouellette, Bhaven N Sampat
1.00
United States Cross-Sectional Studies Patents as Topic Humans Drugs, Generic
Humans Amyotrophic Lateral Sclerosis Male Middle Aged Female
1.00
Humans Male Female Drugs, Generic Drug Costs

Expanding the antiprotozoal activity and the mechanism of action of n-butyl and iso-butyl ester of quinoxaline-1,4-di-

Alonzo González-González, Oscar Sánchez-Sánchez, Lilián Yépez-Mulia et al.
1.00
Giardia lamblia Trichomonas vaginalis Entamoeba histolytica Antiprotozoal Agents Quinoxalines

Classifications MeSH